Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18398081 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Epanova™ (Omega-3 Free Fatty Acids)
2 Completed EPANOVA in Crohn's Disease, Study 1
Condition: Crohn's Disease
Intervention: Drug: Epanova

Indicates status has not been verified in more than two years